Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Common symptoms like blood in urine or frequent urination should prompt a visit to a urologist. Early evaluation is crucial for effective bladder cancer management. Consult a urologist promptly for ...

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

Dr Ademola Oyekan consultant radiation and clinical oncologist at the Lagos State University (LASUTH) speaks with Gboyega Alaka on Prostate cancer, why it is rampant among people of black race, plus ...

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...

Joshi, MD, MPH. A panelist discusses how identifying intermediate-risk patients, managing disease heterogeneity in non–muscle-invasive bladder cancer, and addressing long-term care needs present key ...